BTK and COVID-19: Third, the potential beneficial effect of BTK inhibitors on the amelioration of the COVID-19 clinical course [21] was principally due to the modulation of immunological response [22, 23], other than through the notable platelet inhibition effect [24] of BTK inhibitors.